The solution structure of the anti-HIV chemokine vMIP-II

Protein Science

Volumn 8, Issue 11, 1999, Pages 2270-2280

  Liwang, Andy C ^a   Wang, Zi Xuan ^b   Sun, Yi ^b   Peiper, Stephen C ^b   LiWang, Patricia J ^a,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Chemokine; KSHV; NMR; Structure; VMIP

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 2;

ARTICLE; CARBOXY TERMINAL SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE;

HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032698481     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.8.11.2270     Document Type: Article

References (96)

1. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. 1996. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
2. 15N with side chair Hβ resonances in larger proteins. J Magn Reson 95:636-641.
3. Baggiolini M. 1998. Chemokines and leukocyte traffic. Nature 329:565-568.
4. Baggiolini M, Dewald B, Moser B. 1997. Human chemokines: An update. Annu Rev Immunol 15:615-705.
5. Bax A, Grzesiek S. 1993. Methodological advances in protein NMR. Acc Chem Res 26:131-138.
6. 13C J couplings in a 20-kDa protein-peptide complex. J Am Chem Soc 114:6923-6925.
7. Bax A, Vuister GW, Grzesiek S, Delaglio F, Wang AC, Tschudin R, Zhu G. 1994. Quantitative J correlation. Methods Enzymol 239:79-105.
8. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644.
9. Bewley CA, Gustafson KR, Boyd MR, Covell DG, Bax A, Clore MG, Gronenborn AM. 1998. Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nat Struct Biol 5:571-578.
10. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/ fusin and blocks HIV-1 entry. Nature 382:829-833.
11. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani MA, Sasaki T, Williams TJ, Gray PW, Moore PS, et al. 1997. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278: 290-294.
12. Brünger AT. 1992. X-PLOR version 3.1: A system for X-ray crystallography and NMR. New Haven, Connecticut: Yale University Press.
13. Burrows SD, Doyle ML, Murphy KP, Franklin SG, White JR, Brooks I, McNulty DE, Scott MO, Knutson JR, Porter D, et al. 1994. Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. Biochemistry 33:12741-12745.
14. Christopher JA. 1998. SPOCK: The structural properties observation and calculation kit (Program Manual). College Station, Texas: Center for Macromolecular Design, Texas A&M University.
15. Chung C, Cooke RM, Proudfoot AEI, Wells TNC. 1995. The three-dimensional solution structure of RANTES. Biochemistry 34:3907-9314.
16. Clark-Lewis I, Kim K-S, Rajarathnam K, Gong J-H, Dewald B, Moser B, Baggiolini M, Sykes BD. 1995. Structure-activity relationships of chemokines. J Leukoc Biol 57:703-711.
17. Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM. 1990. Three dimensional structure of interleukin-8 in solution. Biochemistry 29:1689-1696.
18. Clore GM, Gronenborn AM. 1991. Structures of larger proteins in solution: Three-and four-dimensional heteronuclear NMR spectroscopy. Science 252:1390-1399.
19. Clore GM, Gronenborn AM. 1998. Determining the structures of larger proteins and protein complexes by NMR. Trends Biotechnol 16:22-34.
20. Combadiere C, Ahuja SK, Tiffany HL, Murphy PM. 1996. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1α, MIP-1β, and RANTES. J Leukoc Biol 60:147-152.
21. Crump MP, Gong J-H, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier J-L, Baggiolini M, Sykes B, Clark-Lewis I. 1997. Solution structure and the basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 16:6996-7007.
22. Crump MP, Rajarathnam K, Kim K-S, Clark-Lewis I, Sykes BD. 1998. Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation. J Biol Chem 273:22471-22479.
23. Dealwis C, Fernandez EJ, Thompson DA, Simon RJ, Siani MA, Lolis E. 1998. Crystal structure of chemically synthesized [N33A]SDF-1a, a potent ligand for the HIV-1 "Fusin" co-receptor. Proc Natl Acad Sci USA 95:6941-6946.
24. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
25. Doms RW, Peiper SC. 1997. Unwelcome guests with master keys: How HIV uses chemokine receptors for cellular entry. Virology 235:179-190.
26. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
27. Fairbrother WJ, Reilly D, Colby TJ, Hesselgesser J, Horuk R. 1994. The solution structure of melanoma growth stimulating activity. J Mol Biol 242: 252-270.
28. Farrow NA, Muhandiram R, Singer AU, Pascal SM, Kay CM, Gish G, Shoelson SE, Pawson T, Forman-Kay JD, Kay LE. 1994. Backbone dynamics of a free and a phosphopeptide-complexed Src homology 2 domain by 15N NMR relaxation. Biochemistry 33:5984-6003.
29. αH coupling constants on protein structure determination by NMR. J Magn Reson Ser B 104:99-103.
30. 2-terminal residues. J Exp Med 181:631-640.
31. Gong J-H, Uguccioni M, Dewald B, Baggiolini M, Clark-Lewis I. 1996. RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem 271:10521-10527.
32. Graham GJ, MacKenzie J, Lowe S, Tsang L-S, Weatherbee JA, Issacson A, Medicherla J, Fang F, Wilkinson PC, Pragnell IB. 1994. Aggregation of the chemokine MIP-1α is a dynamic and reversible phenomenon. J Biol Chem 269:4974-4978.
33. Graham GJ, Wilkinson PC, Nibbs RJB, Lowe S, Kolset SO, Parker A, Freshney MG, Tsang ML-S, Pragnell IB. 1996. Uncoupling stem cell inhibition from monocyte chemoattraction in MIP-1a by mutagenesis of the proteoglycan binding site. EMBO J 15:6506-6515.
34. 15N relaxation measurements. J Mol Biol 230:364-372.
35. β J couplings in isotopically enriched proteins. J Am Chem Soc 117:5312-5315.
36. cc couplings between backbone carbonyl and methyl carbons in isotopically enriched proteins. J Biomol NMR 3:487-493.
37. Hadley TJ, Peiper SC. 1997. From malaria to chemokine receptor: The emerging physiologic role of the Duffy blood group antigen. Blood 89: 3077-3091.
38. 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer. Biochemistry 35:6569-6584.
39. Hanzawa H, Haruyama H, Konishi K, Watanahe K, Tsurufuji S. 1998. Solution structure of CINC/Gro investigated by heteronuclear NMR. J Biochem 123:62-70.
40. Holmes WE, Lee J, Kuang W-J, Rice GC, Wood WI. 1991. Structure and functional expression of a human interleukin-8 receptor. Science 253:1278-1280.
41. Hoogewerf AJ, Kuschert GSV, Proudfoot AEI, Borlat F, Clark-Lewis I, Power CA, Wells TNC. 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36:13570-13578.
42. Kuy LE, Torchia DA, Bax A. 1989. Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: Application to staphylococcal nuclease. Biochemistry 28:8972-8979.
43. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, et al. 1994. Lymphotactin: A cytokine that represents a new class of chemokine. Science 266:1395-1399.
44. Kim K-S, Clark-Lewis I, Sykes BD. 1994. Solution structure of GRO/melanoma growth stimulatory activity determined by 1H NMR spectroscopy. J Biol Chem 269:32909-32915.
45. Kim K-S, Rajarathnam K, Clark-Lewis I, Sykes BD. 1996. Structural characterization of a monomeric chemokine: Monocyte chemoattractant protein-3. FEBS Lett 395:277-282.
46. Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, Power CA. Luttichau HR, Gerstoft J, Clapham PR, et al. 1997. A broad-spectrum chemokine antagonist encoded by Kaposi's Sarcoma-associated herpesvirus. Science 277:1656-1659.
47. Koopmann W, Krangel MS. 1997. Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1α. J Biol Chem 272:10103-10109.
48. Kuboniwa H, Grzesiek S, Delaglio F, Bax A. 1994. Measurement of HN-Hα J couplings in calcium-free calmodulin using new 2D and 3D water-flip-back methods. J Biomol NMR 4:871-878.
49. Kuszewski J, Gronenborn AM, Clore GM. 1996. Improving the quality of NMR and crystallographic protein structures by means of a conformational database potential derived from structure databases. Protein Sci 5:1067-1080.
50. Kuszewski J, Gronenborn AM, Clore GM. 1997. Improvements and extensions in the conformational database potential for the refinement of NMR and X-ray structures of proteins and ucleic acids. J Magn Reson 125:171-177.
51. Kuszewski J, Nilges M, Brünger AT. 1992. Sampling and efficiency of metric matrix distance geometry: A novel "partial" matrix algorithm. J Biomol NMR 2:33-56.
52. Laskowski RA, MacArthur MW, Moss DS, Thornton JW. 1993. PROCHECK: A program to check to stereochemical quality of protein structures. J Appl Crystallogr 26:283-291.
53. Laurence JS, LiWang AC, LiWang PJ. 1998. The effect of N-terminal truncation and solution conditions on chemokine dimer stability: Nuclear magnetic resonance structural analysis of macrophage inflammatory protein 1β mutants. Biochemistry 37:9346-9354.
54. Leong SR, Lowman HB, Liu J, Shire S, Deforge LE, Gillece-Castro BL, McDowell R, Hébert CA. 1997. IL-8 single-chain homodimers and heterodimers: Interactions with the chemokine receptors CXCR1, CXCR2, and DARC. Protein Sci 6:609-617.
55. LiWang AC, Cao JJ, Zheng H, Lu Z, Peiper SC, LiWang PJ. 1999. Dynamics study on the anti-human immunodeficiency virus chemokine vrial macrophage inflammatory protein-II (vMIP-II) reveals a fully monomeric protein. Biochemistry 38:442-453.
56. Lodi PJ, Garrett DS, Kuszewski J, Tsang ML-S, Weatherbee JA, Leonard WJ, Gronenborn AM, Clore GM. 1994. High-resolution solution structure of the β chemokinehMIP-1β by multidimensional NMR. Science 263:1762-1767.
57. MacArthur MW, Thornton JM. 1991. Influence of proline residues on protein conformation. J Mol Biol 218:397-412.
58. 15N-labeled proteins. J Biomol NMR 3:239-244.
59. Mayo K, Roongta V, Ilyina E, Milius R, Barker S. 1995. NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: A symmetric tetramer. Biochemistry 34:11399-11409.
60. 1H two-dimensional NMR spectroscopy. Biochemistry 36:4412-4422.
61. Minor DL, Kim PS. 1994. Measurement of the β-sheet-forming propensities of amino acids. Nature 367:660-663.
62. Mizoue LS, Bazan JF, Johnson EC, Handel TM. 1999. Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1. Biochemisiry 38:1402-1414.
63. Moore PS, Boshoff C, Weiss RA, Chang Y. 1996. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739-1744.
64. Moser B, Dewald B, Barella L, Schumacher C, Baggiolini M, Clark-Lewis I. 1993. Interleukin-8 antagonists generated by N-terminal modification. J Biol Chem 268:7125-7128.
65. Murphy PM, Tiffany HL. 1991. Cloning and complementary DNa encoding a functional human interleukin-8 receptor. Science 253:1280-1283.
66. Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ. 1993. Molecular cloning, functional expression, and signalling characteristics of a C-C chemokine receptor. Cell 72:415-425.
67. Nilges M, Clore GM, Gronenborn AM. 1988. Determination of the three-dimensional structure of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations. FEBS Lett 229:317-324.
68. Nilges M, Kuszewski J, Brünger AT. 1991. In: Hoch JC, ed. Computational aspects of the study of biological macromolecules by NMR. New York: Plenum Press.
69. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier J-L, Arenzana-Seisdedos F, Schwartz O, Heard J-M, Clark-Lewis I, Legler DF, et al. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833-835.
70. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9:617-648.
71. Paavola CD, Hemmerich S, Grunberger D, Polsky I, Bloom A, Freedman R, Mulkins M, Bhakta S, McCarley D, Wiesent L, et al. 1998. Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MICP-1 receptor CCR2B. J Biol Chem 273:33157-33165.
72. Pakianathan DR, Kuta EG, Artis DR, Skelton NJ, Hebert CA. 1997. Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3, and CCR5. Biochemistry 36:9642-9648.
73. Paolini JF, Willard D, Consler T, Luther M, Krangel MS. 1994. The chemokines IL-8, monocyte chemoattractant protein-1, I-309 are monomers at physiologically relevant concentrations. J Immunol 153:2704-2717.
74. Rajarathnam K, Kay CM, Dewald B, Wolf M, Baggiolini M, Clark-Lewis I, Sykes BD. 1997. Neutrophil-activating peptide-2 and melanoma growth-stimulatory activity are functional as monomers for neutrophil activation. J Biol Chem 272:1725-1729.
75. Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M, Clark-Lewis I. 1994. Neutrophil activation by monomeric interleukin-8. Science 264:90-92.
76. Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF. 1996. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1β, and MIP-1α. J Biol Chem 271: 17161-17166.
77. Richardson JS. 1981. The anatomy and taxonomy of protein structure. Adv Protein Chem 34:167-339.
78. Rollins BJ. 1997. Chemokines. Blood 90:909-928.
79. Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M. 1996. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. J Biol Chem 35:3362-3367.
80. Schall TJ. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3:165-183.
81. Schraufslatter IU, Ma M, Oades ZG, Barritt DS, Cochrane CG. 1995. The role of Tyr13 and Lys15 of interleukin-8 in the high affinity interaction with the interleukin-8 receptor type A. J Biol Chem 270:10428-10431.
82. Shao W, Fernandez E, Wilken J, Thompson DA, Siani MA, West J, Lolis E, Schweitzer BI. 1998a. Accessibility of selenomethionine proteins by total chemical synthesis: Structural studies of human herpesvirus-8 MIP-II. FEBS Lett 441:17-82.
83. Shao W, Jerva LF, West J, Lolis E, Schweitzer BI. 1998b. Solution structure of murine macrophage inflammatory protein-2. Biochemistry 37:8303-8313.
84. Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, Buser R, Wells TNC, Proudfoot AEI. 1997. Potent inhibition of HIV-1 infectivity in macrophages and lyphocytes by a novel CCR5 antagonist. Science 276:276-279.
85. Skelton NJ, Aspiras F, Ogez J, Schall TJ. 1995. Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. Biochemistry 34:5329-5342.
86. Sozzani S, Luini W, Bianchi G, Allavena P, Wells TNC, Napolitano M, Bernardini G, Vecchi A, D'Ambrosio D, Mazzeo D, et al. 1998. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 92:4035-4039.
87. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 367:79-82.
88. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting. Nucl Acids Res 22:4673-4680.
89. 15N-enriched proteins. J Am Chem Soc 115:7772-7777.
90. 13C. J Am Chem Soc 115:5334-5335.
91. Wagner L, Yang OO, Garcia-Zepeda EA, Ge Y, Kalams SA, Walker BD, Pasternack MS, Luster AD. 1998. β-Chemokines are released from HIV-1 specific cytolytic T-cell granules complexed to proteoglycans. Nature 391:908-911.
92. 2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J Exp Med 183:681-685.
93. Wells TNC, Power CA, Lusti-Narasimhan M, Hoogewerf AJ, Cooke RM, Chung C, Peitsch MC, Proudfoot AEI. 1996. Selectivity and antagonism of chemokine receptors. J Leukoc Biol 59:53-60.
94. 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 6:135-140.
95. Zhang X, Chen L, Bancroft DP, Lai CK, Maione TE. 1994. Crystal structure of human platelet factor 4. Biochemistry 33:8361-8366.
96. Zhang Y, Rollins BJ. 1995. A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Mol Cell Biol 15:4851-4855.